Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-10-008430)

Filing Details

Accession Number:: 0001225208-10-008430
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-17 13:00:00
Reporting Period:: 2010-03-15

Filing Date:: 2010-03-17
Accepted Time:: 2010-03-17 12:25:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202294	Elliot Sigal	345 Park Avenue New York NY 10154	Evp, Cso & President R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	Disposition	2010-03-15	47,563	$25.94	142,222	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	1,417	Indirect	By BMY Savings & Investment Program

Footnotes

Includes unvested restricted stock awards.
Based on a plan statement as of the end of the most recent fiscal quarter.